Neuropsychological Outcome of Different Treatments for Young Children with Medulloblastoma, Ependymoma and PNET: Multicenter Trial HIT 2000

被引：0

作者：

Ottensmeier, H. ^{[1
]}

Schlegel, P. G. ^{[2
]}

Wolff, J. E. ^{[3
]}

Eyrich, M. ^{[4
]}

Juhnke, B. O. ^{[5
]}

von Hoff, K. ^{[5
]}

Frahsek, S. ^{[1
]}

Fleischhack, G. ^{[6
]}

von Bueren, A. ^{[7
]}

Friedrich, C. ^{[8
]}

Mynarek, M. ^{[5
]}

Resch, A. ^{[8
]}

Warmuth-Metz, M. ^{[9
]}

Krauss, J. ^{[10
]}

Kortmann, R. D. ^{[11
]}

Bode, U. ^{[12
]}

Kuehl, J. ^{[1
]}

Rutkowski, S. ^{[5
]}

机构：

[1] Univ Wurzburg, Childrens Hosp, Dept Pediat Oncol, Wurzburg, Germany

[2] Univ Wurzburg, Childrens Hosp, Dept Pediat Oncol, Comprehens Canc Ctr Mainfranken, Wurzburg, Germany

[3] Cleveland Clin, Childrens Hosp, Dept Pediat Hematol Oncol, Cleveland, OH 44106 USA

[4] Univ Med Ctr Wuerzburg, Dept Pediat Hematol & Oncol, Wurzburg, Germany

[5] Univ Med Ctr Hamburg Eppendorf, Dept Pediat Hematol & Oncol, Hamburg, Germany

[6] Univ Essen Gesamthsch, Pediat Oncol 3, Essen, Germany

[7] Univ Hosp Geneva, Dept Pediat & Adolescent Med, Div Pediat Oncol, Geneva, Switzerland

[8] Univ Childrens Hosp Rostock, Dept Hematol Oncol, Rostock, Germany

[9] Univ Med Ctr Wuerzburg, Dept Neuroradiol, Hit Natl Refenrence Ctr 2000, Wurzburg, Germany

[10] Univ Med Ctr Wuerzburg, Dept Pediat Neurosurg, Wurzburg, Germany

[11] Univ Leipzig, Dept Radiotherapy, Leipzig, Germany

[12] Univ Bonn, Dept Pediat Oncol, Bonn, Germany

来源：

PEDIATRIC BLOOD & CANCER | 2017年 / 64卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-572

引用

页码：S427 / S427

页数：1

共 41 条

[31] CHROMOSOME 1q GAIN AS GENETIC MARKER FOR RISK STRATIFICATION OF PEDIATRIC EPENDYMOMA PATIENTS - RESULTS FROM THE GERMAN MULTICENTER HIT2000 TRIAL
Pietsch, Torsten
Doerner, Evelyn
zur Muehlen, Anja
Velez-Char, Natalia
Warmuth-Metz, Monika
Kortmann, Rolf
von Hoff, Katja
Friedrich, Carsten
Rutkowski, Stefan
von Bueren, Andre
NEURO-ONCOLOGY, 2013, 15 : 23 - 23
[32] PATTERN OF CHROMOSOMAL ALTERATIONS AS GENETIC MARKER FOR RISK STRATIFICATION OF PEDIATRIC EPENDYMOMA PATIENTS - VALIDATION AS AN ADVERSE PROGNOSTIC MARKER IN THE GERMAN MULTICENTER HIT2000 TRIAL
Pietsch, Torsten
Mynarek, Martin
Doerner, Evelyn
zur Muehlen, Anja
Warmuth-Metz, Monika
Kortmann, Rolf
von Buehren, Andre
Friedrich, Carsten
von Hoff, Katja
Rutkowski, Stefan
NEURO-ONCOLOGY, 2014, 16 : 23 - 24
[33] NEUROPSYCHOLOGICAL OUTCOME IN PEDIATRIC BRAIN TUMOR PATIENTS: FIRST RESULTS FOR PATIENTS OLDER THAN 4 YEARS TREATED WITHIN THE HIT 2000 TRIAL
Resch, Anika
von Hoff, Katja
von Bueren, Andre O.
Friedrich, Carsten
Treulieb, Wiebke
Lindow, Christine
Kwiecien, Robert
Ottensmeier, Holger
Rutkowski, Stefan
NEURO-ONCOLOGY, 2012, 14 : 111 - 112
[34] QUALITY ASSURANCE IN CEREBROSPINAL FLUID CYTOLOGY ASSESSMENT FOR MEDULLOBLASTOMA STAGING LEADS TO POTENTIAL IMPROVED RISK-GROUP ASSESSMENT IN THE PROSPECTIVE MULTICENTER HIT-2000 TRIAL
Hagel, Christian
Sloman, Veronika
Mynarek, Martin
Petrasch, Katharina
Obrecht, Denise
Deinlein, Frank
Schmid, Renate
von Bueren, Andre O.
Friedrich, Carsten
Juhnke, B. Ole
Gerber, Nicolas U.
Kwiecien, Robert
Girschick, Hermann
Hoeller, Alexandra
Zapf, Antonia
von Hoff, Katja
Rutkowski, Stefan
NEURO-ONCOLOGY, 2020, 22 : 425 - 426
[35] Quality of Survival and Growth in Children and Young Adults in the PNET4 European Controlled Trial of Hyperfractionated Versus Conventional Radiation Therapy for Standard-Risk Medulloblastoma
Kennedy, Colin
Bull, Kim
Chevignard, Mathilde
Culliford, David
Doerr, Helmuth G.
Doz, Francois
Kortmann, Rolf-Dieter
Lannering, Birgitta
Massimino, Maura
Navajas Gutierrez, Aurora
Rutkowski, Stefan
Spoudeas, Helen A.
Calaminus, Gabriele
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 88 (02): : 292 - 300
[36] ANALYSIS OF CHROMOSOME 1Q GAIN AS GENETIC MARKER FOR RISK STRATIFICATION OF PEDIATRIC EPENDYMOMA PATIENTS - VALIDATION AS AN ADVERSE PROGNOSTIC MARKER IN THE GERMAN MULTICENTER HIT2000 TRIAL
Velez-Char, Natalia
Doerner, Evelyn
zur Muehlen, Anja
Vladimirova, Valentina
Warmuth-Metz, Monika
Kortmann, Rolf
von Hoff, Katja
Friedrich, Carsten
Rutkowski, Stefan
von Bueren, Andre O.
Pietsch, Torsten
NEURO-ONCOLOGY, 2012, 14 : 38 - 39
[37] Chromosome 1q gain as genetic marker for risk stratification of pediatric ependymoma patients - validation as an adverse prognostic marker in the German multicenter HIT2000 trial.
Pietsch, Torsten
Doemer, Evelyn
zur Muehlen, Anja
Velez-Char, Natalia
Warmuth-Metz, Monika
Kortmann, Rolf-Dieter
von Hoff, Katja
Friedrich, Carsten
Rutkowski, Stefan
von Bueren, Andre O.
CANCER RESEARCH, 2013, 73 (08)
[38] Excellent outcome of young children with nodular desmoplastic medulloblastoma treated on "Head Start" III: a multi-institutional, prospective clinical trial
Dhall, Girish
O'Neil, Sharon H.
Ji, Lingyun
Haley, Kelley
Whitaker, Ashley M.
Nelson, Marvin D.
Gilles, Floyd
Gardner, Sharon L.
Allen, Jeffrey C.
Cornelius, Albert S.
Pradhan, Kamnesh
Garvin, James H.
Olshefski, Randal S.
Hukin, Juliette
Comito, Melanie
Goldman, Stewart
Atlas, Mark P.
Walter, Andrew W.
Sands, Stephen
Sposto, Richard
Finlay, Jonathan L.
NEURO-ONCOLOGY, 2020, 22 (12) : 1862 - 1872
[39] TOXICITY AND OUTCOME IN ADOLESCENT AND YOUNG ADULTS (AYA) TREATED FOR MEDULLOBLASTOMA (MB) AND PRIMITIVE NEUROECTODERMAL TUMORS (PNET) ON COG-A9961 AND CCG-99701: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP (COG)
Farzingohar, Shadi
Xia, Caihong
Sposto, Richard
Freyer, David
Dhall, Girish
NEURO-ONCOLOGY, 2016, 18 : 120 - 120
[40] HEAD START III: A PROSPECTIVE MULTINATIONAL PROTOCOL FOR NEWLY DIAGNOSED CNS EMBRYONAL TUMORS (MEDULLOBLASTOMA AND OTHER PRIMITIVE NEUROECTODERMAL TUMORS |PNET|) OF YOUNG CHILDREN WITH AN IRRADIATION-AVOIDING STRATEGY. FIRST REPORT OF RESPONSE TO AND OUTCOME OF INDUCTION CHEMOTHERAPY
Finlay, Jonathan L.
Haley, Kelley
Dhall, Girish
Gardner, Sharon
Allen, Jeffrey
Cornelius, Albert
Olshefski, Randy
Garvin, James
Pradhan, Kamnesh
Etzl, Michael
Goldman, Stewart
Atlas, Mark
Thompson, Stephen
Hirt, Andreas
Hukin, Juliette
Comito, Melanie
Bertolone, Salvatore
Torkildson, Joseph
Joyce, Michael
Moertel, Christopher
Letterio, John
Kennedy, Gloria
Walter, Andrew
Ji, Lingyun
Sposto, Richard
NEURO-ONCOLOGY, 2010, 12 : 69 - 70

← 1 2 3 4 5 →